Dr. Ashare is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Dhmc Department Of Medicine
Lebanon, NH 03756Phone+1 603-650-5533
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1999 - 2002
- Vanderbilt University School of MedicineClass of 1999
Certifications & Licensure
- VT State Medical License 2022 - 2026
- NH State Medical License 2009 - 2025
- IA State Medical License 1999 - 2010
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Start of enrollment: 2014 Jan 01
- Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung Start of enrollment: 2014 Apr 01
- Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- Inferring forced expiratory volume in 1 second (FEV1) from mobile ECG signals collected during quiet breathing.Maria T Nyamukuru, Alix Ashare, Kofi M Odame
Physiological Measurement. 2025-03-20 - Binding and neutralising antibodies to respiratory syncytial virus and influenza A virus in serum and bronchoalveolar lavage fluid of healthy adults in the United Stat...Amber I Raja, Ruth I Connor, Alix Ashare, Joshua A Weiner, Wendy F Wieland-Alter
Vaccine. 2025-03-03 - Acute respiratory distress vs healthy lung environments differently affect mesenchymal stromal cell extracellular vesicle miRNAs.Sara Rolandsson Enes, Irakli Dzneladze, Thomas H Hampton, Samuel L Neff, Lori Asarian
Cytotherapy. 2025-01-20
Journal Articles
- Evolution of Drug Resistance in an Antifungal-Naive Chronic Candida Lusitaniae InfectionAlix Ashare, MD, Proceedings of the National Academy of Sciences
Grant Support
- Mechanisms of Impaired Inflammation Resolution in Cystic Fibrosis Lung DiseaseDARTMOUTH-HITCHCOCK CLINIC2024–2028
- Mechanisms of Impaired Inflammation Resolution in Cystic Fibrosis Lung DiseaseDARTMOUTH-HITCHCOCK CLINIC2024–2028
- Mechanisms of Impaired Inflammation Resolution in Cystic Fibrosis Lung DiseaseDARTMOUTH-HITCHCOCK CLINIC2024–2028
- Macrophage Pathogen Interactions in Regional Cystic Fibrosis Lung InflammationDARTMOUTH-HITCHCOCK CLINIC2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: